Medidata Solutions Inc (MDSO) Holdings Lifted by Edmond DE Rothschild Holding S.A.

Share on StockTwits

Edmond DE Rothschild Holding S.A. raised its stake in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 23.0% during the fourth quarter, HoldingsChannel reports. The firm owned 64,144 shares of the company’s stock after purchasing an additional 12,000 shares during the quarter. Edmond DE Rothschild Holding S.A.’s holdings in Medidata Solutions were worth $4,325,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. First Trust Advisors LP lifted its holdings in Medidata Solutions by 1,080.5% during the 3rd quarter. First Trust Advisors LP now owns 55,259 shares of the company’s stock worth $4,051,000 after buying an additional 50,578 shares during the period. Victory Capital Management Inc. acquired a new position in shares of Medidata Solutions in the 3rd quarter valued at about $2,256,000. Los Angeles Capital Management & Equity Research Inc. lifted its stake in shares of Medidata Solutions by 29.1% in the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 12,275 shares of the company’s stock valued at $900,000 after purchasing an additional 2,770 shares during the period. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of Medidata Solutions by 48.9% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 707,698 shares of the company’s stock valued at $51,881,000 after purchasing an additional 232,532 shares during the period. Finally, Swiss National Bank lifted its stake in shares of Medidata Solutions by 1.4% in the 3rd quarter. Swiss National Bank now owns 103,300 shares of the company’s stock valued at $7,573,000 after purchasing an additional 1,400 shares during the period.

Shares of Medidata Solutions stock opened at $74.96 on Friday. Medidata Solutions Inc has a one year low of $60.10 and a one year high of $88.87. The stock has a market capitalization of $4.64 billion, a P/E ratio of 78.08, a PEG ratio of 5.10 and a beta of 1.36. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.71 and a quick ratio of 2.71.

Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Tuesday, February 12th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.08. Medidata Solutions had a return on equity of 10.03% and a net margin of 8.17%. The business had revenue of $167.19 million during the quarter, compared to analyst estimates of $168.08 million. During the same period in the previous year, the company posted $0.41 EPS. The firm’s revenue was up 18.1% compared to the same quarter last year. Analysts expect that Medidata Solutions Inc will post 0.8 EPS for the current fiscal year.

MDSO has been the topic of a number of recent analyst reports. BidaskClub downgraded Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Monday, January 7th. Zacks Investment Research downgraded Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Wednesday, December 19th. Finally, TheStreet downgraded Medidata Solutions from a “b” rating to a “c+” rating in a research note on Thursday, December 20th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $83.64.

In other Medidata Solutions news, EVP Michael Pray sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $76.50, for a total transaction of $1,147,500.00. Following the completion of the sale, the executive vice president now directly owns 77,134 shares of the company’s stock, valued at approximately $5,900,751. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert Taylor sold 2,120 shares of the business’s stock in a transaction that occurred on Monday, January 7th. The stock was sold at an average price of $64.70, for a total value of $137,164.00. Following the sale, the director now directly owns 41,916 shares of the company’s stock, valued at $2,711,965.20. The disclosure for this sale can be found here. Insiders sold a total of 49,357 shares of company stock valued at $3,705,792 over the last ninety days. 4.70% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4222876/medidata-solutions-inc-mdso-holdings-lifted-by-edmond-de-rothschild-holding-s-a.html.

Medidata Solutions Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

See Also: What is a back-end load?

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

CooTek   Rating Increased to Hold at Zacks Investment Research
CooTek Rating Increased to Hold at Zacks Investment Research
Barrington Research Analysts Give Atento  a $10.00 Price Target
Barrington Research Analysts Give Atento a $10.00 Price Target
Short Interest in IsoRay, Inc.  Drops By 6.8%
Short Interest in IsoRay, Inc. Drops By 6.8%
Mitie Group PLC  Receives Consensus Recommendation of “Buy” from Brokerages
Mitie Group PLC Receives Consensus Recommendation of “Buy” from Brokerages
Critical Comparison: Weatherford International  versus Its Peers
Critical Comparison: Weatherford International versus Its Peers
Sanford C. Bernstein Analysts Give Beiersdorf  a €91.00 Price Target
Sanford C. Bernstein Analysts Give Beiersdorf a €91.00 Price Target


© 2006-2019 Ticker Report